Theratechnologies Price Fair Value from 2010 to 2024

THTX Stock  USD 1.29  0.08  6.61%   
Theratechnologies Price Fair Value yearly trend continues to be fairly stable with very little volatility. Price Fair Value is likely to outpace its year average in 2024. During the period from 2010 to 2024, Theratechnologies Price Fair Value regression line of annual values had r-squared of  0.0008 and arithmetic mean of  31.59. View All Fundamentals
 
Price Fair Value  
First Reported
2010-12-31
Previous Quarter
(1.80)
Current Value
(1.71)
Quarterly Volatility
58.55386804
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Theratechnologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Theratechnologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.1 M, Total Revenue of 98.7 M or Gross Profit of 75 M, as well as many indicators such as Price To Sales Ratio of 0.56, Dividend Yield of 0.0 or Days Sales Outstanding of 62.42. Theratechnologies financial statements analysis is a perfect complement when working with Theratechnologies Valuation or Volatility modules.
  
Check out the analysis of Theratechnologies Correlation against competitors.
For more information on how to buy Theratechnologies Stock please use our How to Invest in Theratechnologies guide.

Latest Theratechnologies' Price Fair Value Growth Pattern

Below is the plot of the Price Fair Value of Theratechnologies over the last few years. It is Theratechnologies' Price Fair Value historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Theratechnologies' overall financial position and show how it may be relating to other accounts over time.
Price Fair Value10 Years Trend
Very volatile
   Price Fair Value   
       Timeline  

Theratechnologies Price Fair Value Regression Statistics

Arithmetic Mean31.59
Geometric Mean15.03
Coefficient Of Variation185.37
Mean Deviation35.91
Median20.36
Standard Deviation58.55
Sample Variance3,429
Range257
R-Value0.03
Mean Square Error3,689
R-Squared0.0008
Significance0.92
Slope0.38
Total Sum of Squares48,000

Theratechnologies Price Fair Value History

2024 -1.71
2023 -1.8
2022 -2.0
2021 -36.84
2020 68.49
2019 220.17
2018 37.87

About Theratechnologies Financial Statements

Theratechnologies investors use historical fundamental indicators, such as Theratechnologies' Price Fair Value, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Theratechnologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Price Fair Value(1.80)(1.71)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Theratechnologies Stock Analysis

When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.